Tenth Place: Highly Cited MSK Publication from 2010

Posted on by

Based on a SCOPUS search conducted in late January 2011, looking for the top 15 highly cited MSK Publications, the following reference was cited 35 times and is ranked in tenth place. View the journal or search for the specific reference at the journal’s home page by clicking on the journal title below. For additional information about cited reference searching, contact Reference Services.

  • Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, Van Ballegooijen M, Goede SL, Ries LA.  Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.  Cancer. 2010;116(3):544-573.

Eleventh Place: Highly Cited MSK Publication from 2010

Posted on by

Based on a SCOPUS search conducted in late January 2010, looking for the top 15 highly cited MSK Publications, the following reference was cited 33 times and is ranked in eleventh place. View the journal or search for the specific reference at the journal’s home page by clicking on the journal title below. For additional information about cited reference searching, contact Reference Services.

  • Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen, TS, Nigg EA, Brunak S, Mann M. Quantitative phosphoproteomics revealswidespread full phosphorylation site occupancy during mitosis. Science Signaling. 2010;3(104).

MSKCC in the News: January 26 – February 9

Posted on by
  • Dr. Monica Morrow of MSKCC was quoted in a New York Times article regarding a study she coauthored, which was recently published in The Journal of the American Medical Association, that revealed that removing cancerous lymph nodes proved unnecessary for many women with early breast cancer who had undergone chemotherapy and radiation.
  • Charles Sawyers, a cancer expert and Howard Hughes Medical Institute Investigator at MSKCC, in a Wall Street Journal article responded to recent findings that have identified a combination of four genes that appear to play a critical role in determining whether prostate cancer in its early stages will go on to become an aggressive, lethal disease.
  • MESOTHELIOMAhelp.net announced a collaboration between MSKCC and Agenus to test a cancer vaccine that is meant to activate and expand the “army” of T-cells, known to be responsible for killing tumor cells, and inhibit the agent that blocks T-cell signals from effectively killing the tumor.